Aqemia
aqemia.com
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Aqemia is a Paris company founded in 2019 that designs drug candidates with quantum-inspired statistical physics and deep learning. Its platform predicts binding affinity without experimental training data, allowing very large virtual screening campaigns. The company runs its own therapeutic programmes and partners with pharmaceutical groups such as Sanofi.
News
Report
Aqemia raises $38M to find new drugs by meshing theoretical physics with GenAI
Aqemia, a French startup that's meshing "quantum-inspired physics" with machine learning to find new drugs, has raised $38M.
Read more
Report
Pro access
Upgrade to see all 7 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.